1. Home
  2. NWGL vs CTXR Comparison

NWGL vs CTXR Comparison

Compare NWGL & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • CTXR
  • Stock Information
  • Founded
  • NWGL 2008
  • CTXR 2007
  • Country
  • NWGL Macau
  • CTXR United States
  • Employees
  • NWGL N/A
  • CTXR N/A
  • Industry
  • NWGL
  • CTXR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • CTXR Health Care
  • Exchange
  • NWGL Nasdaq
  • CTXR Nasdaq
  • Market Cap
  • NWGL 26.2M
  • CTXR 23.0M
  • IPO Year
  • NWGL 2023
  • CTXR N/A
  • Fundamental
  • Price
  • NWGL $1.03
  • CTXR $1.29
  • Analyst Decision
  • NWGL
  • CTXR Strong Buy
  • Analyst Count
  • NWGL 0
  • CTXR 3
  • Target Price
  • NWGL N/A
  • CTXR $53.00
  • AVG Volume (30 Days)
  • NWGL 32.5K
  • CTXR 450.0K
  • Earning Date
  • NWGL 05-01-2025
  • CTXR 08-12-2025
  • Dividend Yield
  • NWGL N/A
  • CTXR N/A
  • EPS Growth
  • NWGL N/A
  • CTXR N/A
  • EPS
  • NWGL N/A
  • CTXR N/A
  • Revenue
  • NWGL $21,539,347.00
  • CTXR N/A
  • Revenue This Year
  • NWGL N/A
  • CTXR N/A
  • Revenue Next Year
  • NWGL N/A
  • CTXR $851.67
  • P/E Ratio
  • NWGL N/A
  • CTXR N/A
  • Revenue Growth
  • NWGL N/A
  • CTXR N/A
  • 52 Week Low
  • NWGL $0.91
  • CTXR $0.65
  • 52 Week High
  • NWGL $6.61
  • CTXR $15.25
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 37.66
  • CTXR 46.63
  • Support Level
  • NWGL $1.30
  • CTXR $1.23
  • Resistance Level
  • NWGL $1.45
  • CTXR $1.57
  • Average True Range (ATR)
  • NWGL 0.13
  • CTXR 0.11
  • MACD
  • NWGL -0.01
  • CTXR 0.01
  • Stochastic Oscillator
  • NWGL 6.36
  • CTXR 28.21

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About CTXR Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.

Share on Social Networks: